Relating neocortical pathology to disability progression in multiple sclerosis using MRI.

Relating neocortical pathology to disability progression in multiple sclerosis using MRI.

Cortical grey matter (cGM) develops a substantial burden of pathology in multiple sclerosis (MS). Previous cross-sectional studies have suggested a relationship between measures of cortical atrophy and disability. Our objective was to develop a method for automatically measuring the apparent cGM thi...

Full description

Bibliographic Details
Main Authors:	Chen, J, Narayanan, S, Collins, D, Smith, S, Matthews, P, Arnold, D
Format:	Journal article
Language:	English
Published:	2004

Similar Items

Neocortical neuronal, synaptic, and glial loss in multiple sclerosis.
by: Wegner, C, et al.
Published: (2006)

Modifying disability in progressive multiple sclerosis.
by: Palace, J, et al.
Published: (2014)

Modifying disability in progressive multiple sclerosis
by: Palace, J, et al.
Published: (2014)

Association between pathological and MRI findings in multiple sclerosis.
by: Filippi, M, et al.
Published: (2012)

Association between pathological and MRI findings in multiple sclerosis
by: Filippi, M, et al.
Published: (2012)

Demyelinated neocortical lesions in marmoset autoimmune encephalomyelitis mimic those in multiple sclerosis.
by: Pomeroy, I, et al.
Published: (2005)

Demyelinated neocortical lesions in marmoset autoimmune encephalomyelitis mimic those in multiple sclerosis.
by: Pomeroy, I, et al.
Published: (2005)

The pathology of multiple sclerosis and related disorders
by: Moore, G, et al.
Published: (2011)

Primary progressive multiple sclerosis: Brain MRI findings
by: Kremenchutzky, M, et al.
Published: (1999)

Diagnostic brain MRI findings in primary progressive multiple sclerosis.
by: Kremenchutzky, M, et al.
Published: (2000)

Functional brain reorganization for hand movement in patients with multiple sclerosis: defining distinct effects of injury and disability.
by: Reddy, H, et al.
Published: (2002)

Functional brain reorganization for hand movement in patients with multiple sclerosis: Defining distinct effects of injury and disability
by: Reddy, H, et al.
Published: (2002)

Brain dysconnectivity relates to disability and cognitive impairment in multiple sclerosis
by: Sjogard, M, et al.
Published: (2020)

Automated feature extraction for predicting multiple sclerosis patient disability using brain MRI
by: Muslim, Ali M., et al.
Published: (2022)

Monitoring disease activity and progression in primary progressive multiple sclerosis using MRI: sub-voxel registration to identify lesion changes and to detect cerebral atrophy.
by: Stevenson, V, et al.
Published: (2002)

Beta-Interferon treatment does not always slow the progression of axonal injury in multiple sclerosis.
by: Parry, A, et al.
Published: (2003)

beta-interferon treatment does not immediately slow the progression of axonal injury in multiple sclerosis
by: Parry, A, et al.
Published: (2002)

Lipid-related genetic polymorphisms significantly modulate the association between lipids and disability progression in multiple sclerosis
by: Zhang, Y, et al.
Published: (2019)

How patients with multiple sclerosis acquire disability
by: Lublin, FD, et al.
Published: (2022)

Automated feature extraction on brain MRI images for predicting multiple sclerosis patient disability
by: M. Muslim, Ali
Published: (2022)

Diffuse axonal and tissue injury in patients with multiple sclerosis with low cerebral lesion load and no disability.
by: De Stefano, N, et al.
Published: (2002)

Age and disability accumulation in multiple sclerosis.
by: Scalfari, A, et al.
Published: (2011)

Discordant white matter N-acetylasparate and diffusion MRI measures suggest that chronic metabolic dysfunction contributes to axonal pathology in multiple sclerosis.
by: Cader, S, et al.
Published: (2007)

COMPARING MRI MEASURES OF MYELIN INTEGRITY AS SURROGATE MARKERS FOR THE CLINICAL EXPRESSION OF PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS
by: Matthews, L, et al.
Published: (2010)

T cells and microglia as drivers of multiple sclerosis pathology.
by: Friese, M, et al.
Published: (2007)

T cells and microglia as drivers of multiple sclerosis pathology
by: Friese, M, et al.
Published: (2007)

Genetic, pathologic, and radiographic correlations in multiple sclerosis
by: Yates, R
Published: (2016)

Spinal cord neuronal pathology in multiple sclerosis.
by: Gilmore, C, et al.
Published: (2009)

Regional thalamic MRI as a marker of widespread cortical pathology and progressive frontotemporal involvement in amyotrophic lateral sclerosis
by: Tu, S, et al.
Published: (2018)

Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis.
by: Evangelou, N, et al.
Published: (2000)

Defining multiple sclerosis disease activity using MRI T2-weighted difference imaging.
by: Lee, M, et al.
Published: (1998)

AMILORIDE TREATMENT AMELIORATES MRI SURROGATE MARKERS OF NEURODEGENERATION IN PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS
by: Arun, T, et al.
Published: (2012)

Altered transient brain dynamics in multiple sclerosis: treatment or pathology?
by: Van Schependom, J, et al.
Published: (2019)

Oligoclonal bands in multiple sclerosis: clinical-pathologic correlation.
by: Farrell, M, et al.
Published: (1985)

White matter and lesion T1 relaxation times increase in parallel and correlate with disability in multiple sclerosis.
by: Parry, A, et al.
Published: (2002)

MRI results from the European Study on Intravenous Immunoglobulin in Secondary Progressive Multiple Sclerosis (ESIMS).
by: Fazekas, F, et al.
Published: (2005)

MRI assessment of iron deposition in multiple sclerosis.
by: Ropele, S, et al.
Published: (2011)

MRI as an outcome in multiple sclerosis clinical trials.
by: Daumer, M, et al.
Published: (2009)

Progress in deciphering the genetics of multiple sclerosis.
by: Herrera, B, et al.
Published: (2003)

The multiple sclerosis PRISMS study: Prevention of relapses and disability by interferon beta-1a subcutaneously in multiple sclerosis
by: Ebers, G, et al.
Published: (1997)